Christopher L. Antos
- Molecular Biology top 1%
- Cardiology and Cardiovascular Medicine top 1%
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Cell Biology top 2%
- Co-authors
- Eric N. OlsonJames A. RichardsonJeffery D. MolkentinJeffrey RobbinsStephen R. GrantBruce E. MarkhamJianrong LuTimothy A. McKinsey
- Topics
- Signaling Pathways in Disease (9 papers)Congenital heart defects research (6 papers)Cardiac Fibrosis and Remodeling (6 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Christopher L. Antos
30 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 4.8k
- Cardiology and Cardiovascular Medicine 2.1k
- Pathology and Forensic Medicine 795
- Oncology 630
- Cell Biology 601
Countries citing papers authored by Christopher L. Antos
This map shows the geographic impact of Christopher L. Antos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher L. Antos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher L. Antos more than expected).
Fields of papers citing papers by Christopher L. Antos
This network shows the impact of papers produced by Christopher L. Antos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher L. Antos. The network helps show where Christopher L. Antos may publish in the future.
Co-authorship network of co-authors of Christopher L. Antos
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher L. Antos. A scholar is included among the top collaborators of Christopher L. Antos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher L. Antos. Christopher L. Antos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 18 | |
| 5 | 9 | |
| 6 | 7 | |
| 7 | 113 | |
| 8 | 10 | |
| 9 | 31 | |
| 10 | 76 | |
| 11 | 9 | |
| 12 | 21 | |
| 13 | 53 | |
| 14 | 39 | |
| 15 | 21 | |
| 16 | Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition porebreakdown → | 832 |
| 17 | 232 | |
| 18 | Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophybreakdown → | 793 |
| 19 | 98 | |
| 20 | A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophybreakdown → | 2111 |
About Christopher L. Antos
Christopher L. Antos is a scholar working on Developmental Neuroscience, Biological Psychiatry and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 6.2k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (9 papers), Congenital heart defects research (6 papers) and Cardiac Fibrosis and Remodeling (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.1k citations), Molecular Biology (4.8k citations) and Developmental Neuroscience (245 citations). Christopher L. Antos has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Eric N. Olson, James A. Richardson, Jeffery D. Molkentin, Jeffrey Robbins, Stephen R. Grant, Bruce E. Markham, Jianrong Lu, Timothy A. McKinsey, Joseph A. Hill and Shurong Chang. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.